首页> 外文期刊>Analytical Letters >y Validating a Single-Particle ICP-MS Method to Measure Nanoparticles in Human Whole Blood for Nanotoxicology
【24h】

y Validating a Single-Particle ICP-MS Method to Measure Nanoparticles in Human Whole Blood for Nanotoxicology

机译:Y验证单粒子ICP-MS方法,以测量人类全血中的纳米颗粒进行纳米毒理学

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

With the rising use of nanomaterials in everyday objects, an uptake of those materials by humans is very likely. To assess their effect on the body, reliable detection of nanoparticles even in very low amounts in human blood becomes increasingly important. Single-particle (SP) inductively coupled plasma-mass spectrometry (ICP-MS) is a fast and reliable method for counting and sizing particles at lowest concentrations, while simultaneously distinguishing between dissolved and particulate analytes. For the first time to our knowledge, a dedicated method validation approach for silver and gold nanoparticle analysis in human whole blood has been performed. With only little sample preparation, trueness expressed as bias with values below or equal to 5% and imprecision values below 6% for particle size as well as an effective limit of detection of around 20nm are possible. The concentration working range throughout all measured samples was in the nanogram per liter range, making SP-ICP-MS a powerful tool in future nanotoxicological applications and trace analysis of nanoparticles.
机译:随着日常物体中纳米材料的使用升高,人类的吸收很可能是那些材料的吸收。为了评估它们对身体的影响,即使在人血上非常低的量也可靠地检测纳米颗粒变得越来越重要。单粒子(SP)电感耦合等离子体质谱(ICP-MS)是一种快速且可靠的方法,用于以最低浓度计数和施加粒子,同时区分溶解和颗粒分析物。首次了解我们的知识,已经进行了人类全血中银和金纳米粒子分析的专用方法验证方法。只有小样品制备,具有低于或等于5%或等于5%的偏差的真实和粒度低于6%的偏差以及约20nm的有效检测限度。整个测量样品的浓度工作范围在每升纳米范围内,使SP-ICP-MS成为未来纳米毒理学应用中的强大工具和纳米颗粒的痕量分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号